DOT America, Inc.

DOT America, Inc. is a medical device coating and surface treatment specialist serving the orthopedic and dental implant industries. Based in Columbia City, Indiana, the company provides comprehensive surface preparation and coating services for medical implants and surgical instruments. Core offerings include PVD (physical vapor deposition) coatings for wear resistance; titanium plasma spray (TPS) coatings to promote osseointegration and bone growth; hydroxyapatite (HA)-sprayed coatings for rapid bone tissue formation; bone on-growth surface treatments to address implant loosening; Type II anodizing (DOTIZE®) for abrasion resistance and fatigue strength; and Type III color anodizing for multi-component implant systems requiring color differentiation for ease of use. The company also provides surface preparation services including polishing, micro-blasting, passivation, electro-polishing, and laser marking/engraving for FDA Unique Device Identification compliance. DOT America holds FDA facility registration #3011461101 and maintains ISO 13485:2016 certification through Intertek. The company operates as the US subsidiary of DOT GmbH (Rostock, Germany) and commenced operations in 2015 with an investment of approximately $4.5 million in Indiana. Products serve orthopedic, dental, and general medical device manufacturers seeking outsourced coating and surface modification capabilities. The company functions as both a contract manufacturer and strategic partner, offering integrated solutions for device performance enhancement and supply-chain consolidation.